Therefore, the coupling of various types of cardiovascular diseases with metabolic disorders creates particularly challenging conditions, as it influences the sensitivity of cells to angiotensin peptides, vasopressin, and insulin, and thereby enhances the predisposition to the development of detrimental changes in the heart and vessels of diabetic patients. The gene discussed is INS; the disease is metabolic disease.